Open questions on bioequivalence: the case of cholecalciferol
Cholecalciferol or vitamin D<sub>3</sub> is an endogenous substance with the typical problems of bioavailability/bioequivalence of this class of substances. A previous trial has shown that, if administered orally at a dose of 800-10,000 IU and bioassayed as its 25-hydroxy metabolite, a slow absorpti...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications
2013-09-01
|
| Edice: | Italian Journal of Medicine |
| Témata: | |
| On-line přístup: | http://www.italjmed.org/index.php/ijm/article/view/429 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|